FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions
The federal agency has assigned a target action date of January 31, 2026, for a decision.
Food Insecurity and the Dangers of Infant Formula Dilution
FDA will not meet original PDUFA date for sebetralstat to treat HAE
Though the decision will not meet the June 17, 2025, target date, the federal agency anticipates a decision within approximately 4 weeks.
Demystifying Infant Formula
Father’s teen diet linked to children’s healthy eating habits
Research presented at NUTRITION 2025 shows that fathers with improved adolescent diets are more likely to model and monitor healthy eating for their children.
Weekly review: Clesrovimab for RSV approved, new dupilumab data, and more
Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.
